{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:42:14Z","timestamp":1756381334214,"version":"3.44.0"},"reference-count":42,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,11,23]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is nowadays the most common liver disease worldwide. Autoimmune hepatitis (AIH) is a relatively rare disease of the liver characterised by female predominance, circulating autoantibodies, polyclonal hypergammaglobulinaemia, interface hepatitis on histology and favourable response to immunosuppression. The possibility of an additional AIH diagnosis in patients with NAFLD (NAFLD\/AIH concurrence) or the presence of AIH alone instead of a supposed NAFLD diagnosis represents a challenge for clinicians. We report herein two adult patients (a 33-year-old woman and a 59-year-old man) with a previous NAFLD diagnosis who proved finally to suffer from AIH alone. These two representative cases indicate how difficult and complicated could be sometimes the diagnosis of patients with AIH highlighting the range of disease manifestations and severity while they also underline that although NAFLD is by far the most frequent chronic liver disease this could not be always the case.<\/jats:p>","DOI":"10.1136\/bcr-2020-238400","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T18:18:21Z","timestamp":1608661101000},"page":"e238400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-8464","authenticated-orcid":false,"given":"Georgios N","family":"Dalekos","sequence":"first","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Thessaly, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos K","family":"Gatselis","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Thessaly, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K","family":"Koukoulis","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, University of Thessaly, Larissa, Thessaly, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"2025082804030366000_13.12.e238400.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2025082804030366000_13.12.e238400.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"key":"2025082804030366000_13.12.e238400.3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"2025082804030366000_13.12.e238400.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.02.001","article-title":"NAFLD and autoimmune hepatitis: do not judge a book by its cover","volume":"75","author":"Dalekos","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025082804030366000_13.12.e238400.5","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2025082804030366000_13.12.e238400.6","first-page":"186A","article-title":"Hepatic steatosis and\/or steatohepatitis in primary biliary cholangitis: an innocent bystander or a guilty player?","volume":"64(Suppl)","author":"Gatselis","year":"2016","journal-title":"Hepatology"},{"key":"2025082804030366000_13.12.e238400.7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12046","article-title":"Non-alcoholic fatty liver disease in patients with autoimmune hepatitis","volume":"2","author":"Takahashi","year":"2018","journal-title":"JGH Open"},{"key":"2025082804030366000_13.12.e238400.8","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S0618-8278(19)30779-0","article-title":"FRI-029-Non-alcoholic fatty liver disease and steatohepatitis in autoimmune hepatitis: important player or innocent bystander?","volume":"70","author":"Zachou","year":"2019","journal-title":"J Hepatol"},{"key":"2025082804030366000_13.12.e238400.9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"2025082804030366000_13.12.e238400.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"2025082804030366000_13.12.e238400.11","first-page":"1","article-title":"Hellenic association for the study of the liver clinical practice guidelines: autoimmune hepatitis","volume":"32","author":"Dalekos","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"2025082804030366000_13.12.e238400.12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12470"},{"key":"2025082804030366000_13.12.e238400.13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2025082804030366000_13.12.e238400.14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","volume":"49","author":"Zachou","year":"2019","journal-title":"Hepatol Res"},{"key":"2025082804030366000_13.12.e238400.15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33(Suppl 2)","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"key":"2025082804030366000_13.12.e238400.16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"2025082804030366000_13.12.e238400.17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2025082804030366000_13.12.e238400.18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun"},{"key":"2025082804030366000_13.12.e238400.19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"key":"2025082804030366000_13.12.e238400.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.032"},{"key":"2025082804030366000_13.12.e238400.21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025082804030366000_13.12.e238400.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(02)00089-4"},{"key":"2025082804030366000_13.12.e238400.23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.15111","article-title":"Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International autoimmune hepatitis group research workshop","volume":"49","author":"Dyson","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025082804030366000_13.12.e238400.24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"2025082804030366000_13.12.e238400.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01851.x"},{"key":"2025082804030366000_13.12.e238400.26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1665-2681(19)30914-7","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","volume":"13","author":"Rigopoulou","year":"2014","journal-title":"Ann Hepatol"},{"key":"2025082804030366000_13.12.e238400.27","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(94)90128-7"},{"key":"2025082804030366000_13.12.e238400.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.03.008"},{"key":"2025082804030366000_13.12.e238400.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.08.011"},{"key":"2025082804030366000_13.12.e238400.30","first-page":"bcr2015209387","article-title":"Spontaneous bacterial peritonitis: an unusual manifestation of brucellosis in a previous healthy male patient","volume":"2015","author":"Makaritsis","year":"2015","journal-title":"Case Rep Child Meml Hosp Chic"},{"key":"2025082804030366000_13.12.e238400.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.08.002"},{"key":"2025082804030366000_13.12.e238400.32","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1007\/s10620-016-4258-3","article-title":"Nonalcoholic fatty liver disease in patients with autoimmune hepatitis: further reason for teeth gnashing?","volume":"61","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2025082804030366000_13.12.e238400.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"2025082804030366000_13.12.e238400.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24080"},{"key":"2025082804030366000_13.12.e238400.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.03.005"},{"key":"2025082804030366000_13.12.e238400.36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J Hepatol"},{"key":"2025082804030366000_13.12.e238400.37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology Committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025082804030366000_13.12.e238400.38","doi-asserted-by":"crossref","DOI":"10.1186\/1740-2557-4-3","article-title":"The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders","volume":"4","author":"Papamichalis","year":"2007","journal-title":"J Autoimmune Dis"},{"key":"2025082804030366000_13.12.e238400.39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2010.07.013","article-title":"Recognizing autoimmune hepatitis: scores help, but no more","volume":"54","author":"Lohse","year":"2011","journal-title":"J Hepatol"},{"key":"2025082804030366000_13.12.e238400.40","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181c74e0d"},{"key":"2025082804030366000_13.12.e238400.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135486","article-title":"Low serum hepcidin in patients with autoimmune liver diseases","volume":"10","author":"Lyberopoulou","year":"2015","journal-title":"PLoS One"},{"key":"2025082804030366000_13.12.e238400.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179074","article-title":"Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis","volume":"12","author":"Taubert","year":"2017","journal-title":"PLoS One"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:03:19Z","timestamp":1756378999000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,21]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bcr-2020-238400"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238400","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}